Mortality according to cd4 count at start of combination antiretroviral therapy among hiv-infected patients followed for up to 15 years after start of treatment: collaborative cohort study

HIGHLIGHTS

• who: Combination antiretroviral, therapy (ART) and HIV/AIDS, from the SchoolUniversity of Barcelona, Spain have published the research: Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study, in the Journal: (JOURNAL) of 31/07/2013
• how: The authors investigated how long patients bear the burden of increased mortality due to starting ART with low CD4 counts by studying the prognostic value of baseline CD4 count for mortality up to 15 years after start of ART using . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.